Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1.
Immunofluorescence of monoclonal antibody to CBR3 on HeLa cell . [antibody concentration 10 ug/ml]
Western Blot analysis of CBR3 expression in transfected 293T cell line by CBR3 monoclonal antibody (M05), clone 1G8.Lane 1: CBR3 transfected lysate (Predicted MW: 30.9 KDa).Lane 2: Non-transfected lysate.
CBR3 monoclonal antibody (M05), clone 1G8. Western Blot analysis of CBR3 expression in HepG2.
Enzyme-Linked Immunosorbent Assay
Detection limit for recombinant GST tagged CBR3 is 0.3 ng/ml as a capture antibody.
Requested From: United States
Date Requested: 10/26/2016